Re: USA ZHCLF investors
in response to
by
posted on
Oct 30, 2022 05:17PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"True, but given that I sold all my RVX shares and put a sizeable portion of the proceeds into ZHCLF shares, I'm unable to fully appreciate this flip-side problem."
haha...got a chuckle out of that one.
Good discussion!
Koo